10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $323,318 | -72.2% | 7,838 | -62.4% | 0.01% | -43.5% |
| Q2 2023 | $1,164,934 | +101.7% | 20,862 | +101.6% | 0.02% | -30.3% |
| Q1 2023 | $577,427 | -22.4% | 10,350 | -49.3% | 0.03% | +43.5% |
| Q4 2022 | $744,106 | +264.8% | 20,420 | +185.0% | 0.02% | +27.8% |
| Q3 2022 | $204,000 | -33.3% | 7,166 | +6.0% | 0.02% | -30.8% |
| Q2 2022 | $306,000 | -22.9% | 6,758 | +29.5% | 0.03% | -7.1% |
| Q1 2022 | $397,000 | -31.4% | 5,217 | +34.3% | 0.03% | -31.7% |
| Q4 2021 | $579,000 | +73.9% | 3,886 | +70.0% | 0.04% | +41.4% |
| Q3 2021 | $333,000 | -21.8% | 2,286 | +5.0% | 0.03% | -23.7% |
| Q2 2021 | $426,000 | +9.5% | 2,177 | +1.3% | 0.04% | -5.0% |
| Q1 2021 | $389,000 | +86.1% | 2,149 | +45.3% | 0.04% | +66.7% |
| Q4 2020 | $209,000 | +2.5% | 1,479 | -79.4% | 0.02% | +33.3% |
| Q3 2011 | $204,000 | – | 7,166 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |